These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 27278054)

  • 1. Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study.
    Lamberti M; Siracusano R; Italiano D; Alosi N; Cucinotta F; Di Rosa G; Germanò E; Spina E; Gagliano A
    Paediatr Drugs; 2016 Aug; 18(4):319-29. PubMed ID: 27278054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical Trial.
    DeVane CL; Charles JM; Abramson RK; Williams JE; Carpenter LA; Raven S; Gwynette F; Stuck CA; Geesey ME; Bradley C; Donovan JL; Hall AG; Sherk ST; Powers NR; Spratt E; Kinsman A; Kruesi MJ; Bragg JE
    Pharmacotherapy; 2019 Jun; 39(6):626-635. PubMed ID: 31063671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.
    Tramontina S; Zeni CP; Ketzer CR; Pheula GF; Narvaez J; Rohde LA
    J Clin Psychiatry; 2009 Apr; 70(5):756-64. PubMed ID: 19389329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and tolerability of switching to aripiprazole from risperidone in subjects with autism spectrum disorders: a prospective open-label study.
    Ishitobi M; Kosaka H; Takahashi T; Yatuga C; Asano M; Tanaka Y; Ueno K; Okazaki R; Omori M; Hiratani M; Tomoda A; Wada Y
    Clin Neuropharmacol; 2013; 36(5):151-6. PubMed ID: 24045605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole in children with attention-deficit/hyperactivity disorder.
    Findling RL; Short EJ; Leskovec T; Townsend LD; Demeter CA; McNamara NK; Stansbrey RJ
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):347-54. PubMed ID: 18759644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using antipsychotics for behavioral problems in children.
    Shafiq S; Pringsheim T
    Expert Opin Pharmacother; 2018 Sep; 19(13):1475-1488. PubMed ID: 30102079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG; Binder C; Turgay A
    J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.
    Handen BL; Aman MG; Arnold LE; Hyman SL; Tumuluru RV; Lecavalier L; Corbett-Dick P; Pan X; Hollway JA; Buchan-Page KA; Silverman LB; Brown NV; Rice RR; Hellings J; Mruzek DW; McAuliffe-Bellin S; Hurt EA; Ryan MM; Levato L; Smith T
    J Am Acad Child Adolesc Psychiatry; 2015 Nov; 54(11):905-15. PubMed ID: 26506581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study.
    Masi G; Gagliano A; Siracusano R; Berloffa S; Calarese T; Ilardo G; Pfanner C; Magazù A; Cedro C
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):120-5. PubMed ID: 22375853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Atomoxetine in Individuals with Attention-Deficit/Hyperactivity Disorder and Low-Functioning Autism Spectrum Disorder.
    Kilincaslan A; Mutluer TD; Pasabeyoglu B; Tutkunkardas MD; Mukaddes NM
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):798-806. PubMed ID: 27228116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopharmacological interventions in autism spectrum disorder.
    Accordino RE; Kidd C; Politte LC; Henry CA; McDougle CJ
    Expert Opin Pharmacother; 2016; 17(7):937-52. PubMed ID: 26891879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overlap Between Autism Spectrum Disorders and Attention Deficit Hyperactivity Disorder: Searching for Distinctive/Common Clinical Features.
    Craig F; Lamanna AL; Margari F; Matera E; Simone M; Margari L
    Autism Res; 2015 Jun; 8(3):328-37. PubMed ID: 25604000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-Response Effects of Long-Acting Liquid Methylphenidate in Children with Attention Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD): A Pilot Study.
    Kim SJ; Shonka S; French WP; Strickland J; Miller L; Stein MA
    J Autism Dev Disord; 2017 Aug; 47(8):2307-2313. PubMed ID: 28474229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial.
    Zeni CP; Tramontina S; Ketzer CR; Pheula GF; Rohde LA
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):553-61. PubMed ID: 19877980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of risperidone and aripiprazole in the treatment of preschool children with disruptive behavior disorder and attention deficit-hyperactivity disorder: A randomized clinical trial.
    Safavi P; Hasanpour-Dehkordi A; AmirAhmadi M
    J Adv Pharm Technol Res; 2016; 7(2):43-7. PubMed ID: 27144151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical Antipsychotics for Irritability in Pediatric Autism: A Systematic Review and Network Meta-Analysis.
    Fallah MS; Shaikh MR; Neupane B; Rusiecki D; Bennett TA; Beyene J
    J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):168-180. PubMed ID: 30707602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive Aripiprazole Treatment for Risperidone-Induced Hyperprolactinemia: An 8-Week Randomized, Open-Label, Comparative Clinical Trial.
    Zhao J; Song X; Ai X; Gu X; Huang G; Li X; Pang L; Ding M; Ding S; Lv L
    PLoS One; 2015; 10(10):e0139717. PubMed ID: 26448615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone augmentation for treatment-resistant aggression in attention-deficit/hyperactivity disorder: a placebo-controlled pilot study.
    Armenteros JL; Lewis JE; Davalos M
    J Am Acad Child Adolesc Psychiatry; 2007 May; 46(5):558-565. PubMed ID: 17450046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Review and Meta-analysis: Efficacy of Pharmacological Interventions for Irritability and Emotional Dysregulation in Autism Spectrum Disorder and Predictors of Response.
    Salazar de Pablo G; Pastor Jordá C; Vaquerizo-Serrano J; Moreno C; Cabras A; Arango C; Hernández P; Veenstra-VanderWeele J; Simonoff E; Fusar-Poli P; Santosh P; Cortese S; Parellada M
    J Am Acad Child Adolesc Psychiatry; 2023 Feb; 62(2):151-168. PubMed ID: 35470032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epistaxis as an Unexpected Side Effect of Aripiprazole and Risperidone Treatment in Two Children with Two Different Psychiatric Diagnosis.
    Binici NC; Güney SA
    J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):759-760. PubMed ID: 28665688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.